Health Care & Life Sciences » Pharmaceuticals | Chengdu Kanghong Pharmaceutical Group Co. Ltd.

Chengdu Kanghong Pharmaceutical Group Co. Ltd.

Chengdu Kanghong Pharmaceutical Group Co. Ltd. A
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.79
Market Cap
CNY28.49 B
Shares Outstanding
621.19 M
Public Float
83.59 M

Profile

Address
No. 36 Shuxi Road
Chengdu Sichuan 610036
China
Employees -
Website http://www.cnkh.com
Updated 07/08/2019
Chengdu Kanghong Pharmaceutical Group Co., Ltd. engages in the research, manufacture and distribution of biological products, traditional Chinese medicines, and chemical drugs. Its products include conbercept ophthalmic injection, songling xuemaikang jiaonang, shugan jieyu jiaonang, kenuoxin jiaonang, danshu jiaonang, yiqing jiaonang, venlafaxine hydrochloride capsules and sustained-release tablets, aripiprazole tablets and orally disintergrating tablets, mosapride citrate dispersible tablets, and dexzopiclone tablet. The company was founded on October 3, 1996 and is headquartered in Chengdu, China.

Financials

View All

Wen Xian Gong
Chairman-Supervisory Board
Xiao Ke
Director & Vice President